Researchers from Japan discover that glucagon-like peptide-2 (GLP-2) analogs can deeply and beneficially reshape the intestinal environment. Short bowel syndrome (SBS) represents one of the most ...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are standard-of-care agents that provide potent glucose-lowering without hypoglycemia, together with weight reduction and cardiovascular and renal ...
This infographic summarizes the main aspects of this longitudinal study—the first study to analyze the changes caused by glucagon-like peptide-2 (GLP-2) analogs to the intestinal environment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results